BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22863934)

  • 1. Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response.
    Shimizu T; Ichihara M; Yoshioka Y; Ishida T; Nakagawa S; Kiwada H
    Biol Pharm Bull; 2012; 35(8):1336-42. PubMed ID: 22863934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
    J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
    Hashimoto Y; Shimizu T; Mima Y; Abu Lila AS; Ishida T; Kiwada H
    Toxicol Appl Pharmacol; 2014 May; 277(1):30-8. PubMed ID: 24632081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
    Wang X; Ishida T; Kiwada H
    J Control Release; 2007 Jun; 119(2):236-44. PubMed ID: 17399838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
    Elsadek NE; Emam SE; Abu Lila AS; Shimizu T; Ando H; Ishima Y; Ishida T
    Biol Pharm Bull; 2020; 43(9):1393-1397. PubMed ID: 32879214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route.
    Takata H; Shimizu T; Yamade R; Elsadek NE; Emam SE; Ando H; Ishima Y; Ishida T
    J Control Release; 2023 Aug; 360():285-292. PubMed ID: 37355210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.
    Ishida T; Ichihara M; Wang X; Yamamoto K; Kimura J; Majima E; Kiwada H
    J Control Release; 2006 May; 112(1):15-25. PubMed ID: 16515818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity.
    Mima Y; Abu Lila AS; Shimizu T; Ukawa M; Ando H; Kurata Y; Ishida T
    J Control Release; 2017 Mar; 250():20-26. PubMed ID: 28179196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics.
    Shimizu T; Abu Lila AS; Awata M; Kubo Y; Mima Y; Hashimoto Y; Ando H; Okuhira K; Ishima Y; Ishida T
    Pharm Res; 2018 Oct; 35(11):223. PubMed ID: 30280273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
    ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.
    Emam SE; Elsadek NE; Abu Lila AS; Takata H; Kawaguchi Y; Shimizu T; Ando H; Ishima Y; Ishida T
    J Control Release; 2021 Jun; 334():327-334. PubMed ID: 33957196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T; Ishida T; Kiwada H
    Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes.
    Shimizu T; Lila ASA; Kitayama Y; Abe R; Takata H; Ando H; Ishima Y; Ishida T
    Biol Pharm Bull; 2024; 47(2):469-477. PubMed ID: 38383000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
    Abu Lila AS; Ichihara M; Shimizu T; Ishida T; Kiwada H
    Biol Pharm Bull; 2013; 36(11):1842-8. PubMed ID: 24189428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y; Shimizu T; Abu Lila AS; Ishida T; Kiwada H
    Biol Pharm Bull; 2015; 38(3):417-24. PubMed ID: 25757923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens.
    Ando H; Abu Lila AS; Kawanishi M; Shimizu T; Okuhira K; Ishima Y; Ishida T
    J Control Release; 2018 Jan; 270():114-119. PubMed ID: 29217175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancer.
    Eto Y; Yoshioka Y; Ishida T; Yao X; Morishige T; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Kiwada H; Nakagawa S
    Biol Pharm Bull; 2010; 33(9):1540-4. PubMed ID: 20823571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.